In fact I suspect the net effect of regulation is actually greater when the regulations aren’t well-defined, because it stops people from trying. It’s awfully difficult to build around something that doesn’t have clear precedent, which is almost everything interesting
Try to raise $100m for a company that wants to seek FDA approval and let me know how it goes
-
-
Not my thing. Just saying it’s not as clear as you make it. It probably should be easier to raise money for bio startups, though. This is arguably a defect of VC more than “regulations are broken” though.
-
It’s ridiculously, ridiculously hard for a company that needs FDA approval to win toneven raise a seed round
-
And yet folks manage to do so. Maybe the bar is higher for hacking bodies than web startups? Maybe that’s not obviously a bad thing? Anyway, just food for thought.
-
The difficulty raising capital for bio startups could also be a problem of impatient capital in inherently slower (vs web) industries. Not arguing either way, just offering something to consider.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.